Par Drugs and Chemicals Limited — Others, 08-08-2025: Copy of Newspaper Publication

Par Drugs and Chemicals has reported strong financial results for the quarter ended June 30, 2025. Total income from operations rose to Rs 26.05 Cr, showing a notable increase. The company's net profit after tax for the period stood at Rs 3.33 Cr, significantly higher than the previous quarter and year-ago period. Earnings per share also increased to Rs 2.70. These results highlight robust operational performance, which is positive for investors as it indicates strong business momentum.